Replies to post #11429 on Innovus Pharmaceuticals Inc. (fka INNV)

[jbdiver]

Thanks Shawn. We'll our fingers crossed. He needs to keep this dilution under control. I think you nailed it holding off on other priduct launch till fluticare bears fruit. Thats the solution right there.
Let me ask you all a question... Are otc companies allowed to sell bonds to leverage or is it such a risky bond that no one would buy it? Why isnt this company weighted in the cost of debt? Excuse me if its a stupid question. :)

[jtaylor68]

Surprisingly, this qualifies as a balanced opinion. You seem to soften up a little.

I also didn't expect any SP movement after the CC.

There has to be a way to get FlutiCare out on the market without further dilution. Another public offering would be huge trouble for this stock.
I doubt West-Ward will agree to a full deferred payment, but maybe Damaj will be able to negotiate an upfront payment with the rest being payed in Q1. After all this is a lucrative deal for both companies so I wouldn't discard the possibility of such an agreement.
Alternatively, they could take out a smaller loan as was used for the BH acquisition. With FlutiCare and millions of revenue from other products in the bag, they should be able to get a loan with more humane conditions than previously.

In any case, FlutiCare has to take precedence and all product launches have to be shelved which could jeopardize FlutiCare financing.